News & Press

Spotlight

Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

Feb 28, 2022

Edenbridge Pharmaceuticals, LLC (“Edenbridge”) today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies throughout the country. To ensure access to patients in need, Edenbridge is sponsoring the DARTISLA ODT Copay Program, which allows eligible patients to obtain the product for as little as $0 when filled through Phil or $20 when filled at other pharmacies.

Read more
All Releases

Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

Feb 28, 2022Read more

Phil Announces Partnership with Impel NeuroPharma in Support of Trudhesa

Sep 27, 2021Read more

Phil Announces up to $100M Strategic Growth Investment

Jun 4, 2021Read more

Lupin Announces Partnership with Phil, Inc. in Support of SOLOSEC

Feb 1, 2021Read more